iShares US Pharmaceuticals ETF
IHE
IHE
91 hedge funds and large institutions have $104M invested in iShares US Pharmaceuticals ETF in 2019 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 34 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
22% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 18
47% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 34
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
91
Holding in Top 10
–
Calls
$755K
Puts
$231K
Top Buyers
| 1 | +$5.99M | |
| 2 | +$4.51M | |
| 3 | +$2.56M | |
| 4 |
Jane Street
New York
|
+$1.93M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.53M |
Top Sellers
| 1 | -$7.84M | |
| 2 | -$1.55M | |
| 3 | -$1.29M | |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
-$1.14M |
| 5 |
Mawer Investment Management
Calgary,
Alberta, Canada
|
-$1.04M |